56,000 bottles of blood pressure medication recalled

56,000 bottles of blood pressure medication recalled

56,000 bottles of blood pressure medication recalled

NMBA (N-Nitroso N-Methyl 4-amino butyric acid) is different than NDEA (N-nitrosodiethylamine) or NDMA, which have been the cause of previous Losartan, Valsartan and Irbesartan recalls.

For more information on the recalled products, visit the FDA's website here.

But patients should speak with their doctor to discuss the recall before they stop taking the drug.

The drugs, including losartan, belong to a class of widely used medicines for treating high blood pressure called angiotensin II receptor blockers, or ARBs. Distributed nationwide online and by pharmacies and retailers including Walmart and Sam's Club, the drug was found to contain trace amounts of a potential human carcinogen, the New Jersey drug company said in a news release.

Camber's recall dwarfs the one by Macleods, as it involves various sizes of tablets (25mg, 50mg 100mg) in various sizes of bottles (30-count, 90-count, 500-count, 1,000-count).

Presently, Illinois-based compliance company Stericycle is working with Camber to notify distributors and customers of the recall.

Meng Wanzhou: Huawei chief executive can be extradited, Canada says
President Trump at one point suggested that the United States could cut a deal with China to secure Meng's release . Extradition cases can stretch on for years, winding in and out of court with many avenues for appeal.

The affected Losartan tablets have expiration dates that run from September 2019 through June 2020.

In a statement, FDA Commissioner Scott Gottlieb explained that the agency has been carrying out a series of investigations for several months after various companies began announcing their voluntary recalls.

United States health regulators said on Friday (March 1) a third cancer-causing toxin was found in some blood pressure pills recalled by India's Hetero Labs a day earlier, adding to a global recall of commonly-used drugs to treat hypertension.

Since last summer, drug companies have recalled hundreds of lots of blood pressure and heart medication drugs after tests showed small levels of potentially cancer-causing impurities.

"The FDA is committed to implementing measures to prevent the formation of these impurities during drug manufacturing processes in the future", he added. Incidentally, Hetero Labs Limited was also listed as the source of the contamination in both recalls.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.